Humacyte, Inc.
HUMANasdaqCIK 1818382HealthcareFiscal year ends Dec 31
Reports and events: 138 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2022-01-1021:05 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-22-002717 |
| 2021-12-2820:10 ET | 8-K/A | 5.02 Departure or appointment of officers or directors | 0001104659-21-153907 |
| 2021-12-2721:05 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001104659-21-153559 |
| 2021-11-1522:09 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-21-139316 |
| 2021-11-1523:42 ET | 10-Q | Quarterly reportPeriod 2021-09-30 | 0001104659-21-138285 |
| 2021-11-1222:09 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-21-138217 |
| 2021-10-2200:38 ET | S-1/A | Registration statement, amended | 0001104659-21-128615 |
| 2021-09-1720:59 ET | S-1 | Registration statement | 0001104659-21-116962 |
| 2021-09-0216:20 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001104659-21-112356 |
| 2021-09-0210:04 ET | SC 13D | Ownership report, active investor | 0001104659-21-112194 |
| 2021-08-3001:14 ET | SC 13D | Ownership report, active investor | 0001104659-21-110679 |
| 2021-08-3001:01 ET | 8-K | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 4.01 Change of auditor; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.06 Item not in the standard list; 9.01 Financial statements and exhibits | 0001104659-21-110678 |
| 2021-08-2510:11 ET | 8-K | 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-21-044669 |
| 2021-08-1720:02 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-21-043426 |
| 2021-08-1620:22 ET | 10-Q | Quarterly reportPeriod 2021-06-30 | 0001213900-21-043027 |
| 2021-08-0421:11 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-21-040339 |
| 2021-06-0721:29 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-21-031280 |
| 2021-05-2620:03 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-21-029327 |
| 2021-05-2120:46 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-21-028423 |
| 2021-05-2020:35 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-21-028185 |
| 2021-05-1720:00 ET | 10-Q | Quarterly reportPeriod 2021-03-31 | 0001213900-21-026966 |
| 2021-05-1420:04 ET | 10-K/A | Annual report, amendedPeriod 2020-12-31 | 0001213900-21-026404 |
| 2021-05-1320:02 ET | 8-K | 4.02 Non-reliance on financial statements; 8.01 Other events | 0001213900-21-026052 |
| 2021-05-0620:03 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-21-024883 |
| 2021-04-2120:07 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-21-022422 |
| 2021-04-1420:08 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-21-021525 |
| 2021-03-0521:07 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-21-013730 |
| 2021-02-1722:09 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-21-010125 |
| 2021-02-1713:45 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-21-009957 |
| 2021-02-1621:02 ET | 10-K | Annual reportPeriod 2020-12-31 | 0001213900-21-009571 |
| 2020-11-1323:46 ET | 10-Q | Quarterly reportPeriod 2020-09-30 | 0001213900-20-036665 |
| 2020-11-0621:07 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-20-035571 |
| 2020-09-2821:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-20-028692 |
| 2020-09-2520:34 ET | SC 13D | Ownership report, active investor | 0001213900-20-028477 |
| 2020-09-2221:10 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-20-027850 |
| 2020-09-1420:45 ET | S-1/A | Registration statement, amended | 0001213900-20-026470 |
| 2020-09-0121:23 ET | S-1/A | Registration statement, amended | 0001213900-20-024845 |
| 2020-08-0421:28 ET | S-1 | Registration statement | 0001213900-20-020196 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:06 ET. Listed shows no prices and gives no investment advice.